DarioHealth Corp (NASDAQ:DRIO) has a beta value of 1.41 and has seen 2.33 million shares traded in the last trading session. The company, currently valued at $58.42M, closed the last trade at $1.53 per share which meant it gained $0.68 on the day or 79.58% during that session. The DRIO stock price is -69.93% off its 52-week high price of $2.60 and 58.82% above the 52-week low of $0.63. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.25 million shares traded. The 3-month trading volume is 121.60K shares.
The consensus among analysts is that DarioHealth Corp (DRIO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
DarioHealth Corp (NASDAQ:DRIO) trade information
Sporting 79.58% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the DRIO stock price touched $1.53 or saw a rise of 1.29%. Year-to-date, DarioHealth Corp shares have moved 94.63%, while the 5-day performance has seen it change 94.68%. Over the past 30 days, the shares of DarioHealth Corp (NASDAQ:DRIO) have changed 99.48%. Short interest in the company has seen 2.01 million shares shorted with days to cover at 17.02.
Wall Street analysts have a consensus price target for the stock at $10.75, which means that the shares’ value could jump 85.77% from current levels. The projected low price target is $7.5 while the price target rests at a high of $14.0. In that case, then, we find that the current price level is -815.03% off the targeted high while a plunge would see the stock gain -390.2% from current levels.
DarioHealth Corp (DRIO) estimates and forecasts
Figures show that DarioHealth Corp shares have outperformed across the wider relevant industry. The company’s shares have gained 27.50% over the past 6 months, with this year growth rate of 57.51%, compared to 14.80% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.16% over the past 5 years.
DRIO Dividends
DarioHealth Corp is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
DarioHealth Corp (NASDAQ:DRIO)’s Major holders
Insiders own 22.90% of the company shares, while shares held by institutions stand at 23.57% with a share float percentage of 30.57%. Investors are also buoyed by the number of investors in a company, with DarioHealth Corp having a total of 40.0 institutions that hold shares in the company. The top two institutional holders are NANTAHALA CAPITAL MANAGEMENT, LLC with over 2.39 million shares worth more than $2.85 million. As of 2024-06-30, NANTAHALA CAPITAL MANAGEMENT, LLC held 6.9429% of shares outstanding.
The other major institutional holder is APPIAN WAY ASSET MANAGEMENT LP, with the holding of over 1.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.64 million and represent 3.9947% of shares outstanding.
